Search

Vaxcyte Inc

Gesloten

SectorGezondheidszorg

56.22 -1.02

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

55.77

Max

56.96

Belangrijke statistieken

By Trading Economics

Inkomsten

-284M

-605M

EPS

-1.97

Werknemers

507

EBITDA

22M

-292M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+83.83% upside

Dividenden

By Acuity

Volgende Winsten

2 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1B

8.8B

Vorige openingsprijs

57.24

Vorige sluitingsprijs

56.22

Nieuwssentiment

By Acuity

50%

50%

113 / 339 Rangschikking in Healthcare

Vaxcyte Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 sep 2026, 19:46 UTC

Vaxcyte Inc is trading modestly higher, having fluctuated throughout the day but remains below its 20-day moving average and near the lower end of its one-month range.

23 sep 2026, 20:02 UTC

Correlated Moves

Vaxcyte Inc shares fell sharply, influenced by a significant drop in the Direxion Daily S&P Biotech Bull 3X ETF and earlier session highs.

18 sep 2026, 20:02 UTC

Vaxcyte Inc shares fell sharply, reaching their lowest cumulative return since Thursday and remaining well below the 20-day moving average.

17 sep 2026, 20:07 UTC

Correlated Moves

Vaxcyte Inc is gaining, likely influenced by the SPDR S&P Biotech ETF's rise following positive Phase 3 results from Moderna's cancer vaccine.

16 sep 2026, 19:16 UTC

Macro Event

Vaxcyte Inc shares fell amid broader market volatility following the Federal Reserve's 25 basis point interest rate hike, remaining near the lower end of their one-month range.

14 sep 2026, 20:08 UTC

Vaxcyte Inc shares are higher today, reflecting broader market trends. Earlier in the session, the stock pulled back but remains above Friday's close.

9 sep 2026, 19:46 UTC

Vaxcyte Inc shares are lower today, fluctuating from an early gain to a mid-afternoon decline. The stock is near its one-month trading range low.

8 sep 2026, 23:31 UTC

Vaxcyte Inc shares declined in after-hours trading, now below their 20-day moving average and near the lower end of their one-month trading range.

4 sep 2026, 20:08 UTC

News

Vaxcyte Inc. appointed new executives and accelerated its timeline for trial data, with shares trading lower during Friday's session.

3 sep 2026, 20:14 UTC

News

Vaxcyte shares are lower in after-market hours following leadership appointments and narrowed guidance for VAX-31 topline data, now expected by October 2026.

2 sep 2026, 20:08 UTC

Vaxcyte Inc is gaining today, driven by strong performance in the Biotechnology sub-sector, despite earlier pulling back from a session high.

1 sep 2026, 20:09 UTC

Vaxcyte Inc shares are lower today, influenced by a broad market decline amid rising oil prices and increasing Treasury yields. No specific company news was identified.

31 aug 2026, 19:16 UTC

Vaxcyte Inc is trading higher since Friday's close, reflecting a positive performance backdrop. Shares remain above their 20-day moving average.

28 aug 2026, 20:07 UTC

Vaxcyte Inc shares are lower amid a broader market downturn. Rising U.S. Treasury yields and inflation concerns contribute to the decline in equity prices.

25 aug 2026, 20:07 UTC

Vaxcyte Inc. shares are lower today, having peaked earlier before drifting downwards. The broader market sees a drop in oil prices and Treasury yields.

24 aug 2026, 19:46 UTC

Vaxcyte Inc's shares are lower amid rising oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 aug 2026, 21:01 UTC

Vaxcyte Inc is trading higher in after-market hours, maintaining a notable increase since Friday's close, amid positive market sentiment.

20 aug 2026, 23:46 UTC

Vaxcyte Inc shares are lower in after-market hours, with no specific news identified. Broader market declines may be affecting investor sentiment in biotechnology.

19 aug 2026, 20:02 UTC

Correlated Moves

Vaxcyte Inc. shares are higher during Wednesday's session, continuing a positive trend with strong investor interest. The stock aligns with gains in the biotechnology sector.

14 aug 2026, 20:06 UTC

Vaxcyte Inc's shares are lower today, breaking a trend of higher closes. This decline aligns with weaker-than-expected U.S. retail sales data for July.

12 aug 2026, 19:46 UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

11 aug 2026, 23:11 UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

10 aug 2026, 19:56 UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

7 aug 2026, 21:01 UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

6 aug 2026, 20:03 UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

5 aug 2026, 19:16 UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

4 aug 2026, 20:21 UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

3 aug 2026, 19:46 UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

31 jul 2026, 19:56 UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

30 jul 2026, 18:52 UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

Peer Vergelijking

Prijswijziging

Vaxcyte Inc Prognose

Koersdoel

By TipRanks

83.83% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 104.6 USD  83.83%

Hoogste 133 USD

Laagste 75 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Vaxcyte Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Sentiment

By Acuity

113 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.